Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy

Diffuse large B-cell lymphoma (DLBCL) is one of the most aggressive non-Hodgkin lymphomas. It is curable but one-third of cases are refractory to therapy or relapse after initial response highlighting the urgent need for developing novel therapeutic approaches. Targeting sirtuins, particularly SIRT1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Hongfeng, He, Meilan, Cheng, Fan, Bai, Rosemary, da Silva, Suzane Ramos, Aguiar, Ricardo C.T., Gao, Shou-Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362454/
https://www.ncbi.nlm.nih.gov/pubmed/28118604
http://dx.doi.org/10.18632/oncotarget.14741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362454/
https://www.ncbi.nlm.nih.gov/pubmed/28118604
http://dx.doi.org/10.18632/oncotarget.14741

Ejemplares similares